Field efficacy and safety of an oral formulation of the novel combination anthelmintic, derquantel-abamectin, in sheep in New Zealand
2010

Efficacy and Safety of Derquantel-Abamectin in Sheep

Sample size: 838 publication Evidence: high

Author Information

Author(s): Little PR, Hodge A, Watson TG, Seed JA, Maeder SJ

Primary Institution: Pfizer Animal Health

Hypothesis

To evaluate the efficacy and safety of the novel anthelmintic combination, derquantel-abamectin, against gastrointestinal nematode populations in sheep, under field-use conditions.

Conclusion

Derquantel-abamectin is highly effective for treating gastrointestinal nematodes in sheep, including resistant populations.

Supporting Evidence

  • The efficacy of derquantel-abamectin against mixed strongyle populations was ≥99.2%.
  • In trials with Nematodirus sp., derquantel-abamectin was 100% effective.
  • Mean bodyweight gain was significantly greater in the derquantel-abamectin group than in negative controls in five trials.

Takeaway

This study shows that a new medicine for sheep can kill bad worms that make them sick, even when other medicines don't work anymore.

Methodology

Controlled faecal egg count reduction tests (FECRT) were conducted in 14 trials across various farms in New Zealand.

Limitations

The study may not represent all sheep farms due to specific geographic and management conditions.

Participant Demographics

Sheep aged 2-12 months, weighing 18.5-53.0 kg, from various breeds.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1080/00480169.2010.67513

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication